ABSTRACT
OBJECTIVE: To evaluate the psychometric properties of the Icelandic version of the Edinburgh Postnatal Depression Scale (EPDS) when used prenatal, explore the dimensionality of the scale and describe its effectiveness in identifying depression. DESIGN: A sample of Icelandic women filled in the EPDS at week 16 gestation, week 24 and week 36. If screened positive in week 16 they were asked to attend a psychiatric diagnostic interview 2-4 weeks later. Every 10th woman screened negative was also asked to attend an interview. SETTING: Antenatal clinics at primary health care centres in Iceland. PARTICIPANTS: In total, 2512 women receiving prenatal care participated in the study. At week 16 gestation, 2397 women filled in the Edinburgh Postnatal Depression Scale, 2025 at week 25, and 1756 at week 36. 474 women attended diagnostic interview two to four weeks after screening. MEASUREMENTS AND FINDINGS: Internal reliability, convergent validity and test-retest correlation of the Icelandic version of the Edinburgh Postnatal Depression Scale appeared acceptable. An exploratory factor analysis supported a one-factor structure of the Edinburgh Postnatal Depression Scale that was confirmed by confirmatory factor analysis showing best fit for one general factor with two group factors. A cut-off score of 11 or higher had specificity of 0.89, sensitivity of 0.80 and positive predictive value of 0.44. KEY CONCLUSIONS AND IMPLICATIONS FOR PRACTICE: The Icelandic version of the Edinburgh Postnatal Depression Scale is a valid and reliable one-dimensional instrument suitable to screen for depression prenatally. We recommend using score 11 or higher as a cut-off. If women score 11, they should be re-assessed two weeks later, but if they score 12 or higher, they should be referred directly for a further assessment. A time gap of two to four weeks does weaken the scale's ability to discriminate between those suffering from Major Depression and those who screen negative.
Subject(s)
Pregnant Women/psychology , Prenatal Diagnosis/standards , Psychometrics/standards , Adult , Area Under Curve , Female , Humans , Iceland , Pregnancy , Prenatal Care/methods , Prenatal Diagnosis/methods , Psychiatric Status Rating Scales/standards , Psychometrics/instrumentation , Psychometrics/methods , ROC Curve , Reproducibility of Results , TranslatingABSTRACT
OBJECTIVE: Few studies are available on the effectiveness of screening tools such as the Edinburgh Postnatal Depression Scale (EPDS) in pregnancy or the extent to which such tools may identify women with mental disorders other than depression. We therefore aimed to investigate the mental health characteristics of pregnant women who screen positive on the EPDS. METHOD: Consecutive women receiving antenatal care in primary care clinics (from November 2006 to July 2011) were invited to complete the EPDS in week 16 of pregnancy. All women who scored above 11 (screen positive) on the EPDS and randomly selected women who scored below 12 (screen negative) were invited to participate in a psychiatric diagnostic interview. RESULTS: 2,411 women completed the EPDS. Two hundred thirty-three women (9.7%) were screened positive in week 16, of whom 153 (66%) agreed to a psychiatric diagnostic interview. Forty-eight women (31.4%) were diagnosed with major depressive disorder according to DSM-IV criteria, 20 (13.1%) with bipolar disorder, 93 (60.8%) with anxiety disorders (including 27 [17.6%] with obsessive-compulsive disorder [OCD]), 8 (5.2%) with dysthymia, 18 (11.8%) with somatoform disorder, 3 (2%) with an eating disorder, and 7 (4.6%) with current substance abuse. Women who screened positive were significantly more likely to have psychosocial risk factors, including being unemployed (χ(2)(1) = 23.37, P ≤.001), lower educational status (χ(2)(1)= 31.68, P ≤ .001), and a history of partner violence (χ(2)(1) = 10.30, P ≤ 001), compared with the women who screened negative. CONCLUSIONS: Use of the EPDS early in the second trimester of pregnancy identifies a substantial number of women with potentially serious mental disorders other than depression, including bipolar disorder, OCD, and eating disorders. A comprehensive clinical assessment is therefore necessary following use of the EPDS during pregnancy to ensure that women who screen positive receive appropriate mental health management.
